Feeding Infant Formula With Added Probiotics and Whey Protein Concentrate
NCT ID: NCT01755481
Last Updated: 2018-01-17
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
800 participants
INTERVENTIONAL
2012-12-31
2017-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Probiotic Formula and Infant Growth
NCT01476397
The Effect of Feeding Infant Formula With Enriched Protein Fractions
NCT02274883
Infant Formula Supplemented With Probiotic Microorganisms and/or Prebiotic.
NCT00836771
Effect of Partially Hydrolyzed, Whey-based Infant Formulas on Growth and Tolerability in Healthy Term Infants
NCT05868408
Observational Study of Infants Fed With Dairy and Plant Based Infant Formula
NCT05804214
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Probiotics F19
F19 in an infant formula
Probiotic
Whey protein concentrate
Whey protein concentrate in an infant formula
Whey protein concentrate
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Probiotic
Whey protein concentrate
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
healthy infants exclusively breast-fed from birth and mothers intending to breastfeed \>80% until at least 5th month of age (meaning through the 4th month of age).
delivered between 37 and 42 weeks of gestation birth weight \>2500 g and \<4000 g parent or the subject's legal representative speak and understand Chinese
Exclusion Criteria
infants fed \>20% infant formula
malformations, handicaps or congenital diseases that could affect normal feeding or growth treatment with antibiotics
2 Weeks
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Arla Foods
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Yongmei Peng, M.D., Ph.D.
Role: PRINCIPAL_INVESTIGATOR
Children's Hospital, Fudan University, Shanghai, China
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Department of Child Health Care, Children's Hospital, Fudan University
Shanghai, , China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
327727-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.